Virtual assistant designed to support dermatologists, family physicians, pediatricians, clinical pharmacists, and nursing staff in the evaluation, diagnosis, severity stratification, treatment, and longitudinal follow-up of acne vulgaris and other pilosebaceous disorders (bacterial and Malassezia folliculitis, gram-negative folliculitis, hidradenitis suppurativa, papulopustular and steroid-induced rosacea, perioral dermatitis, sebaceous hyperplasia, seborrhea), grounded in the best available evidence and current guidelines (AAD, BAD/NICE, EADV, GEMA-acne/Ibero–Latin American consensus statements) as of October 2025.